- directed: true
  graph:
    _id: DB00952_MESH_D008881_1
    disease: Migraine
    disease_mesh: MESH:D008881
    drug: Naratriptan
    drug_mesh: MESH:C106783
    drugbank: DB:DB00952
  links:
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P28221
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P28222
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P30939
    - key: negatively regulates
      source: UniProt:P28221
      target: GO:0150076
    - key: negatively regulates
      source: UniProt:P30939
      target: GO:0150076
    - key: positively regulates
      source: UniProt:P28222
      target: GO:0042310
    - key: positively correlated with
      source: GO:0150076
      target: MESH:D008881
    - key: negatively correlated with
      source: GO:0042310
      target: MESH:D008881
  multigraph: true
  nodes:
    - id: MESH:C106783
      label: Drug
      name: Naratriptan
    - id: UniProt:P28221
      label: Protein
      name: 5-hydroxytryptamine receptor 1D
    - id: UniProt:P28222
      label: Protein
      name: 5-hydroxytryptamine receptor 1B
    - id: UniProt:P30939
      label: Protein
      name: 5-hydroxytryptamine receptor 1F
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: GO:0150076
      label: BiologicalProcess
      name: neuroinflammatory response
    - id: MESH:D008881
      label: Disease
      name: Migraine
  reference:
    - https://go.drugbank.com/drugs/DB00952
    - https://pubmed.ncbi.nlm.nih.gov/31263254/
    - https://pubmed.ncbi.nlm.nih.gov/15911785/
    - https://pubmed.ncbi.nlm.nih.gov/15320857/
- directed: true
  graph:
    _id: DB00612_MESH_D006973_1
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: bisoprolol
    drug_mesh: MESH:D017298
    drugbank: DB:DB00612
  links:
    - key: decreases activity of
      source: MESH:D017298
      target: UBERON:0034729
    - key: positively correlated with
      source: UBERON:0034729
      target: GO:0042310
    - key: decreases activity of
      source: MESH:D017298
      target: UniProt:P08588
    - key: positively correlated with
      source: UniProt:P08588
      target: HP:0033533
    - key: positively correlated with
      source: HP:0033533
      target: HP:0032263
    - key: negatively correlated with
      source: MESH:D017298
      target: GO:0002001
    - key: positively correlated with
      source: GO:0002001
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: positively correlated with
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D017298
      label: Drug
      name: bisoprolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: UBERON:0034729
      label: GrossAnatomicalStructure
      name: sympathetic nerve
    - id: GO:0002001
      label: BiologicalProcess
      name: renin secretion into blood stream
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033533
      label: PhenotypicFeature
      name: Increased cardiac output
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference:
    - https://go.drugbank.com/drugs/DB00612
    - https://en.wikipedia.org/wiki/Bisoprolol#Mechanism_of_action
  comment: At higher doses, bisoprolol antagonizes the B2 adrenergic receptors, but is mainly selective for B1 receptors.
- directed: true
  graph:
    _id: DB00195_MESH_D006973_1
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: betaxolol
    drug_mesh: MESH:D015784
    drugbank: DB:DB00195
  links:
    - key: decreases activity of
      source: MESH:D015784
      target: UniProt:P08588
    - key: participates in
      source: UniProt:P08588
      target: REACT:R-HSA-418555
    - key: increases abundance of
      source: REACT:R-HSA-418555
      target: CHEBI:17489
    - key: positively regulates
      source: REACT:R-HSA-418555
      target: InterPro:IPR005446
    - key: positively correlated with
      source: InterPro:IPR005446
      target: GO:0060047
    - key: positively correlated with
      source: GO:0060047
      target: HP:0032263
    - key: positively correlated with
      source: CHEBI:17489
      target: GO:0060047
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D015784
      label: Drug
      name: betaxolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: REACT:R-HSA-418555
      label: Pathway
      name: G alpha (s) signalling events
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: GO:0060047
      label: BiologicalProcess
      name: heart contraction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference:
    - https://go.drugbank.com/drugs/DB00195#mechanism-of-action
    - https://en.wikipedia.org/wiki/Betaxolol
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL423/
    - https://pubchem.ncbi.nlm.nih.gov/compound/2369#section=Pharmacology-and-Biochemistry
    - https://en.wikipedia.org/wiki/CAMP-dependent_pathway#Importance
  comment: L-type calcium channels are modulated by the adrenergic nervous system, hence betaxolol could indirectly modulate L calcium channels, decreasing heart rate and contraction, ultimately decreasing high blood pressure (https://en.wikipedia.org/wiki/L-type_calcium_channel#Inhibition_and_modulation).
- directed: true
  graph:
    _id: DB00194_MESH_D016849_1
    disease: Herpes simplex keratitis
    disease_mesh: MESH:D016849
    drug: vidarabine
    drug_mesh: MESH:D014740
    drugbank: DB:DB00194
  links:
    - key: has metabolite
      source: MESH:D014740
      target: MESH:D001084
    - key: decreases activity of
      source: MESH:D001084
      target: UniProt:P04293
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0039686
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0090503
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0043631
    - key: in taxon
      source: GO:0043631
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0039686
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0090503
      target: NCBITaxon:10299
    - key: causes
      source: NCBITaxon:10299
      target: MESH:D016849
  multigraph: true
  nodes:
    - id: MESH:D014740
      label: Drug
      name: vidarabine
    - id: MESH:D001084
      label: ChemicalSubstance
      name: Vidarabine Phosphate
    - id: UniProt:P04293
      label: Protein
      name: DNA polymerase catalytic subunit
    - id: GO:0039686
      label: BiologicalProcess
      name: bidirectional double-stranded viral DNA replication
    - id: GO:0090503
      label: BiologicalProcess
      name: RNA phosphodiester bond hydrolysis, exonucleolytic
    - id: GO:0043631
      label: BiologicalProcess
      name: RNA polyadenylation
    - id: NCBITaxon:10299
      label: OrganismTaxon
      name: Human alphaherpesvirus 1 strain 17
    - id: MESH:D016849
      label: Disease
      name: Herpes simplex keratitis
  reference:
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1090/
    - https://en.wikipedia.org/wiki/Vidarabine#Mode_of_action
    - https://go.drugbank.com/drugs/DB00194
  comment: The drug needs to be converted to vidarabine phosphate first (monophosphate --> diphosphate --> triphosphate) to become active and exert its role as inhibitor (https://pubchem.ncbi.nlm.nih.gov/compound/21704#section=Mechanism-of-Action).
- directed: true
  graph:
    _id: DB00194_MESH_D007635_1
    disease: Herpes simplex dendritic keratitis
    disease_mesh: MESH:D007635
    drug: vidarabine
    drug_mesh: MESH:D014740
    drugbank: DB:DB00194
  links:
    - key: has metabolite
      source: MESH:D014740
      target: MESH:D001084
    - key: decreases activity of
      source: MESH:D001084
      target: UniProt:P04293
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0039686
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0090503
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0043631
    - key: in taxon
      source: GO:0043631
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0039686
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0090503
      target: NCBITaxon:10299
    - key: causes
      source: NCBITaxon:10299
      target: MESH:D007635
  multigraph: true
  nodes:
    - id: MESH:D014740
      label: Drug
      name: vidarabine
    - id: MESH:D001084
      label: ChemicalSubstance
      name: Vidarabine Phosphate
    - id: UniProt:P04293
      label: Protein
      name: DNA polymerase catalytic subunit
    - id: GO:0039686
      label: BiologicalProcess
      name: bidirectional double-stranded viral DNA replication
    - id: GO:0090503
      label: BiologicalProcess
      name: RNA phosphodiester bond hydrolysis, exonucleolytic
    - id: GO:0043631
      label: BiologicalProcess
      name: RNA polyadenylation
    - id: NCBITaxon:10299
      label: OrganismTaxon
      name: Human alphaherpesvirus 1 strain 17
    - id: MESH:D007635
      label: Disease
      name: Herpes simplex dendritic keratitis
  reference:
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1090/
    - https://en.wikipedia.org/wiki/Vidarabine#Mode_of_action
    - https://go.drugbank.com/drugs/DB00194
- directed: true
  graph:
    _id: DB01606_MESH_D013203_1
    disease: Infection due to Staphylococcus aureus
    disease_mesh: MESH:D013203
    drug: tazobactam
    drug_mesh: MESH:C043265
    drugbank: DB:DB01606
  links:
    - key: negatively regulates
      source: MESH:C043265
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0030655
    - key: in taxon
      source: GO:0030655
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D013203
  multigraph: true
  nodes:
    - id: MESH:C043265
      label: Drug
      name: tazobactam
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0030655
      label: BiologicalProcess
      name: beta-lactam antibiotic catabolic process
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D013203
      label: Disease
      name: Infection due to Staphylococcus aureus
  reference: https://go.drugbank.com/drugs/DB01606#mechanism-of-action
- directed: true
  graph:
    _id: DB01606_MESH_D001064_1
    disease: Appendicitis
    disease_mesh: MESH:D001064
    drug: tazobactam
    drug_mesh: MESH:C043265
    drugbank: DB:DB01606
  links:
    - key: negatively regulates
      source: MESH:C043265
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0030655
    - key: in taxon
      source: GO:0030655
      target: NCBITaxon:1763
    - key: causes
      source: NCBITaxon:1763
      target: MESH:D001064
  multigraph: true
  nodes:
    - id: MESH:C043265
      label: Drug
      name: tazobactam
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0030655
      label: BiologicalProcess
      name: beta-lactam antibiotic catabolic process
    - id: NCBITaxon:1763
      label: OrganismTaxon
      name: Mycobacterium sp.
    - id: MESH:D001064
      label: Disease
      name: Appendicitis
  reference: https://go.drugbank.com/drugs/DB01606#mechanism-of-action
- directed: true
  graph:
    _id: DB08842_MESH_D000544_1
    disease: Alzheimer's disease
    disease_mesh: MESH:D000544
    drug: acetylcarnitine
    drug_mesh: MESH:D004005
    drugbank: DB:DB08842
  links:
    - key: positively regulates
      source: MESH:D004005
      target: GO:0007271
    - key: positively correlated with
      source: GO:0007271
      target: GO:0014055
    - key: negatively correlated with
      source: GO:0014055
      target: MESH:D000544
    - key: positively regulates
      source: MESH:D004005
      target: GO:0035249
    - key: positively correlated with
      source: GO:0035249
      target: GO:0061535
    - key: negatively correlated with
      source: GO:0061535
      target: MESH:D000544
    - key: increases activity of
      source: MESH:D004005
      target: GO:0005947
    - key: positively regulates
      source: GO:0005947
      target: GO:0006979
    - key: correlated with
      source: GO:0006979
      target: GO:0150076
    - key: positively correlated with
      source: GO:0150076
      target: MESH:D000544
    - key: increases activity of
      source: MESH:D004005
      target: GO:0004129
    - key: positively regulates
      source: GO:0004129
      target: GO:0006979
    - key: correlated with
      source: GO:0006979
      target: GO:0150076
    - key: positively correlated with
      source: GO:0150076
      target: MESH:D000544
    - key: decreases abundance of
      source: MESH:D004005
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: HP:0025464
    - key: positively correlated with
      source: HP:0025464
      target: GO:0150076
    - key: positively correlated with
      source: GO:0150076
      target: MESH:D000544
    - key: increases expression of
      source: MESH:D004005
      target: MESH:D017475
    - key: positively correlated with
      source: MESH:D017475
      target: GO:0007613
    - key: negatively correlated with
      source: GO:0007613
      target: HP:0002354
    - key: positively correlated with
      source: HP:0002354
      target: MESH:D000544
    - key: positively correlated with
      source: MESH:D004005
      target: GO:0018393
    - key: occurs in
      source: GO:0018393
      target: CHEBI:64645
    - key: contributes to
      source: CHEBI:64645
      target: CHEBI:60425
    - key: positively correlated with
      source: CHEBI:60425
      target: MESH:D000544
    - key: positively correlated with
      source: MESH:D004005
      target: GO:0018393
    - key: occurs in
      source: GO:0018393
      target: InterPro:IPR002955
    - key: contributes to
      source: InterPro:IPR002955
      target: HP:0002185
    - key: positively correlated with
      source: HP:0002185
      target: MESH:D000544
  multigraph: true
  nodes:
    - id: MESH:D004005
      label: Drug
      name: acetylcarnitine
    - id: GO:0007271
      label: BiologicalProcess
      name: synaptic transmission, cholinergic
    - id: GO:0014055
      label: BiologicalProcess
      name: acetylcholine secretion, neurotransmission (BP)
    - id: GO:0035249
      label: BiologicalProcess
      name: synaptic transmission, glutamatergic
    - id: GO:0061535
      label: BiologicalProcess
      name: glutamate secretion, neurotransmission (BP)
    - id: GO:0005947
      label: CellularComponent
      name: mitochondrial alpha-ketoglutarate dehydrogenase complex
    - id: GO:0004129
      label: MolecularActivity
      name: cytochrome-c oxidase activity
    - id: GO:0006979
      label: BiologicalProcess
      name: response to oxidative stress
    - id: GO:0150076
      label: BiologicalProcess
      name: neuroinflammatory response
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: HP:0025464
      label: PhenotypicFeature
      name: Increased reactive oxygen species production
    - id: MESH:D017475
      label: GeneFamily
      name: Receptors, Nerve Growth Factor
    - id: GO:0007613
      label: BiologicalProcess
      name: memory
    - id: HP:0002354
      label: PhenotypicFeature
      name: Memory impairment
    - id: GO:0018393
      label: BiologicalProcess
      name: peptidyl-lysine acetylation
    - id: InterPro:IPR002955
      label: GeneFamily
      name: Microtubule-associated protein Tau
    - id: HP:0002185
      label: PhenotypicFeature
      name: Neurofibrillary Tangles
    - id: CHEBI:64645
      label: ChemicalSubstance
      name: amyloid-beta
    - id: CHEBI:60425
      label: ChemicalSubstance
      name: amyloid fibril
    - id: MESH:D000544
      label: Disease
      name: Alzheimer's disease
      alt_ids:
         - MESH:C566998
  reference:
    - https://go.drugbank.com/drugs/DB08842#mechanism-of-action
    - https://www.nature.com/articles/4000805
    - https://en.wikipedia.org/wiki/Acetylcarnitine
    - https://pubmed.ncbi.nlm.nih.gov/16273023/
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791143/
    - https://en.wikipedia.org/wiki/Alzheimer%27s_disease#Causes
    - https://pubmed.ncbi.nlm.nih.gov/8937831/
    - https://pubmed.ncbi.nlm.nih.gov/22729864/
    - https://pubmed.ncbi.nlm.nih.gov/10381209/
    - https://en.wikipedia.org/wiki/Oxoglutarate_dehydrogenase_complex#Pathology
- directed: true
  graph:
    _id: DB00484_MESH_D005902_2
    disease: Open-angle glaucoma
    disease_mesh: MESH:D005902
    drug: brimonidine
    drug_mesh: MESH:D000068438
    drugbank: DB:DB00484
  links:
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P08913
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18089
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18825
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418597
    - key: decreases abundance of
      source: REACT:R-HSA-418594
      target: CHEBI:17489
    - key: decreases abundance of
      source: REACT:R-HSA-418597
      target: CHEBI:17489
    - key: positively correlated with
      source: CHEBI:17489
      target: UBERON:0001796
    - key: regulates
      source: CHEBI:17489
      target: GO:0006939
    - key: regulates
      source: GO:0006939
      target: UBERON:0003956
    - key: positively correlated with
      source: UBERON:0001796
      target: HP:0007906
    - key: negatively correlated with
      source: UBERON:0003956
      target: HP:0007906
    - key: positively correlated with
      source: HP:0007906
      target: MESH:D005902
  multigraph: true
  nodes:
    - id: MESH:D000068438
      label: Drug
      name: brimonidine
    - id: UniProt:P08913
      label: Protein
      name: Alpha-2A adrenergic receptor
    - id: UniProt:P18089
      label: Protein
      name: Alpha-2B adrenergic receptor
    - id: UniProt:P18825
      label: Protein
      name: Alpha-2C adrenergic receptor
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: REACT:R-HSA-418597
      label: Pathway
      name: G alpha (z) signalling events
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: GO:0006939
      label: BiologicalProcess
      name: smooth muscle contraction
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: UBERON:0003956
      label: GrossAnatomicalStructure
      name: aqueous drainage system
    - id: HP:0007906
      label: PhenotypicFeature
      name: Ocular Hypertension
    - id: MESH:D005902
      label: Disease
      name: Open-angle glaucoma
  reference:
    - mhttps://go.drugbank.com/drugs/DB00484#mechanism-of-action
    - https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Aqueous_humour#Clinical_significance
     https://en.wikipedia.org/wiki/Ciliary_body#Clinical_significance
  comment: UBERON:0003956 includes the uveoscleral network as well as other canals for aqueous humor drainage. The uveoscleral network is the structure that seems to be affected by alpha adrenergic agonists, such as brimonidine, specially in long-term treatments (i.e. chronic dosing).
- directed: true
  graph:
    _id: DB00484_MESH_D012393_1
    disease: Rosacea
    disease_mesh: MESH:D012393
    drug: brimonidine
    drug_mesh: MESH:D000068438
    drugbank: DB:DB00484
  links:
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P08913
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18089
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18825
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418597
    - key: decreases abundance of
      source: REACT:R-HSA-418594
      target: CHEBI:17489
    - key: decreases abundance of
      source: REACT:R-HSA-418597
      target: CHEBI:17489
    - key: negatively correlated with
      source: CHEBI:17489
      target: GO:0042310
    - key: negatively correlated with
      source: GO:0042310
      target: HP:0001041
    - key: negatively correlated with
      source: GO:0042310
      target: HP:0031284
    - key: positively correlated with
      source: HP:0031284
      target: MESH:D012393
    - key: positively correlated with
      source: HP:0001041
      target: MESH:D012393
  multigraph: true
  nodes:
    - id: MESH:D000068438
      label: Drug
      name: brimonidine
    - id: UniProt:P08913
      label: Protein
      name: Alpha-2A adrenergic receptor
    - id: UniProt:P18089
      label: Protein
      name: Alpha-2B adrenergic receptor
    - id: UniProt:P18825
      label: Protein
      name: Alpha-2C adrenergic receptor
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: REACT:R-HSA-418597
      label: Pathway
      name: G alpha (z) signalling events
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0031284
      label: PhenotypicFeature
      name: Flushing
    - id: HP:0001041
      label: PhenotypicFeature
      name: Facial erythema
    - id: MESH:D012393
      label: Disease
      name: Rosacea
  reference:
    - https://go.drugbank.com/drugs/DB00484#mechanism-of-action
    - https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Rosacea#Medications
    - https://pubmed.ncbi.nlm.nih.gov/26566370/
  comment: The drug has an anti-inflammatory role which can help with treating some of the signs and symptoms of rosasea.
- directed: true
  graph:
    _id: DB00484_MESH_D009798_2
    disease: Ocular hypertension
    disease_mesh: MESH:D009798
    drug: brimonidine
    drug_mesh: MESH:D000068438
    drugbank: DB:DB00484
  links:
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P08913
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18089
    - key: increases activity of
      source: MESH:D000068438
      target: UniProt:P18825
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418594
    - key: participates in
      source: UniProt:P08913
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18089
      target: REACT:R-HSA-418597
    - key: participates in
      source: UniProt:P18825
      target: REACT:R-HSA-418597
    - key: decreases abundance of
      source: REACT:R-HSA-418594
      target: CHEBI:17489
    - key: decreases abundance of
      source: REACT:R-HSA-418597
      target: CHEBI:17489
    - key: positively correlated with
      source: CHEBI:17489
      target: UBERON:0001796
    - key: regulates
      source: CHEBI:17489
      target: GO:0006939
    - key: regulates
      source: GO:0006939
      target: UBERON:0003956
    - key: positively correlated with
      source: UBERON:0001796
      target: MESH:D009798
    - key: negatively correlated with
      source: UBERON:0003956
      target: MESH:D009798
  multigraph: true
  nodes:
    - id: MESH:D000068438
      label: Drug
      name: brimonidine
    - id: UniProt:P08913
      label: Protein
      name: Alpha-2A adrenergic receptor
    - id: UniProt:P18089
      label: Protein
      name: Alpha-2B adrenergic receptor
    - id: UniProt:P18825
      label: Protein
      name: Alpha-2C adrenergic receptor
    - id: REACT:R-HSA-418594
      label: Pathway
      name: G alpha (i) signalling events
    - id: REACT:R-HSA-418597
      label: Pathway
      name: G alpha (z) signalling events
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: GO:0006939
      label: BiologicalProcess
      name: smooth muscle contraction
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: UBERON:0003956
      label: GrossAnatomicalStructure
      name: aqueous drainage system
    - id: MESH:D009798
      label: Disease
      name: Ocular hypertension
  reference:
    - https://go.drugbank.com/drugs/DB00484#mechanism-of-action
    - https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Aqueous_humour#Clinical_significance
    - https://en.wikipedia.org/wiki/Ciliary_body#Clinical_significance
  comment: UBERON:0003956 includes the uveoscleral network as well as other canals for aqueous humor drainage. The uveoscleral network is the structure that seems to be affected by alpha adrenergic agonists, such as brimonidine, specially in long-term treatments (i.e. chronic dosing).
- directed: true
  graph:
    _id: DB00930_MESH_D006937_1
    disease: Hypercholesterolemia
    disease_mesh: MESH:D006937
    drug: colesevelam
    drug_mesh: MESH:D000069472
    drugbank: DB:DB00930
  links:
    - key: decreases abundance of
      source: MESH:D000069472
      target: CHEBI:47774
    - key: positively correlated with
      source: CHEBI:47774
      target: MESH:D006937
  multigraph: true
  nodes:
    - id: MESH:D000069472
      label: Drug
      name: colesevelam
    - id: CHEBI:47774
      label: ChemicalSubstance
      name: low-density lipoprotein cholesterol
    - id: MESH:D006937
      label: Disease
      name: Hypercholesterolemia
  reference:
    - https://go.drugbank.com/drugs/DB00930
    - https://en.wikipedia.org/wiki/Colesevelam
  comment: Colesevelamid is a type of ion exchange resin (MESH:D007475).
- directed: true
  graph:
    _id: DB00781_MESH_D014605_1
    disease: Uveitis
    disease_mesh: MESH:D014605
    drug: Polymyxin B
    drug_mesh: MESH:D011112
    drugbank: DB:DB00781
  links:
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:16412
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:25051
    - key: negatively regulates
      source: MESH:D011112
      target: InterPro:IPR005025
    - key: part of
      source: CHEBI:16412
      target: GO:0009274
    - key: part of
      source: CHEBI:25051
      target: GO:0009274
    - key: part of
      source: InterPro:IPR005025
      target: GO:0045272
    - key: in taxon
      source: GO:0009274
      target: NCBITaxon:562
    - key: in taxon
      source: GO:0045272
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D014605
  multigraph: true
  nodes:
    - id: MESH:D011112
      label: Drug
      name: Polymyxin B
    - id: CHEBI:16412
      label: ChemicalSubstance
      name: lipopolysaccharide
    - id: CHEBI:25051
      label: ChemicalSubstance
      name: Lipid A
    - id: InterPro:IPR005025
      label: GeneFamily
      name: NADPH-dependent FMN reductase-like
    - id: GO:0009274
      label: CellularComponent
      name: peptidoglycan-based cell wall
    - id: GO:0045272
      label: CellularComponent
      name: plasma membrane respiratory chain complex I
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D014605
      label: Disease
      name: Uveitis
  reference:
    - https://go.drugbank.com/drugs/DB00781#mechanism-of-action
    - https://en.wikipedia.org/wiki/Polymyxin_B#Mechanism_of_action
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355641/
- directed: true
  graph:
    _id: DB00781_MESH_D003234_1
    disease: Bacterial conjunctivitis
    disease_mesh: MESH:D003234
    drug: Polymyxin B
    drug_mesh: MESH:D011112
    drugbank: DB:DB00781
  links:
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:16412
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:25051
    - key: negatively regulates
      source: MESH:D011112
      target: InterPro:IPR005025
    - key: part of
      source: CHEBI:16412
      target: GO:0009274
    - key: part of
      source: CHEBI:25051
      target: GO:0009274
    - key: part of
      source: InterPro:IPR005025
      target: GO:0045272
    - key: in taxon
      source: GO:0009274
      target: NCBITaxon:1279
    - key: in taxon
      source: GO:0045272
      target: NCBITaxon:1279
    - key: causes
      source: NCBITaxon:1279
      target: MESH:D003234
  multigraph: true
  nodes:
    - id: MESH:D011112
      label: Drug
      name: Polymyxin B
    - id: CHEBI:16412
      label: ChemicalSubstance
      name: lipopolysaccharide
    - id: CHEBI:25051
      label: ChemicalSubstance
      name: Lipid A
    - id: InterPro:IPR005025
      label: GeneFamily
      name: NADPH-dependent FMN reductase-like
    - id: GO:0009274
      label: CellularComponent
      name: peptidoglycan-based cell wall
    - id: GO:0045272
      label: CellularComponent
      name: plasma membrane respiratory chain complex I
    - id: NCBITaxon:1279
      label: OrganismTaxon
      name: Staphylococcus sp
    - id: MESH:D003234
      label: Disease
      name: Bacterial conjunctivitis
  reference:
    - https://go.drugbank.com/drugs/DB00781#mechanism-of-action
    - https://en.wikipedia.org/wiki/Polymyxin_B#Mechanism_of_action
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355641/
- directed: true
  graph:
    _id: DB00781_MESH_D014552_1
    disease: Urinary tract infectious disease
    disease_mesh: MESH:D014552
    drug: Polymyxin B
    drug_mesh: MESH:D011112
    drugbank: DB:DB00781
  links:
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:16412
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:25051
    - key: negatively regulates
      source: MESH:D011112
      target: InterPro:IPR005025
    - key: part of
      source: CHEBI:16412
      target: GO:0009274
    - key: part of
      source: CHEBI:25051
      target: GO:0009274
    - key: part of
      source: InterPro:IPR005025
      target: GO:0045272
    - key: in taxon
      source: GO:0009274
      target: NCBITaxon:562
    - key: in taxon
      source: GO:0045272
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D014552
  multigraph: true
  nodes:
    - id: MESH:D011112
      label: Drug
      name: Polymyxin B
    - id: CHEBI:16412
      label: ChemicalSubstance
      name: lipopolysaccharide
    - id: CHEBI:25051
      label: ChemicalSubstance
      name: Lipid A
    - id: InterPro:IPR005025
      label: GeneFamily
      name: NADPH-dependent FMN reductase-like
    - id: GO:0009274
      label: CellularComponent
      name: peptidoglycan-based cell wall
    - id: GO:0045272
      label: CellularComponent
      name: plasma membrane respiratory chain complex I
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D014552
      label: Disease
      name: Urinary tract infectious disease
  reference:
    - https://go.drugbank.com/drugs/DB00781#mechanism-of-action
    - https://en.wikipedia.org/wiki/Polymyxin_B#Mechanism_of_action
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355641/
- directed: true
  graph:
    _id: DB00781_MESH_D010032_1
    disease: Otitis externa
    disease_mesh: MESH:D010032
    drug: Polymyxin B
    drug_mesh: MESH:D011112
    drugbank: DB:DB00781
  links:
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:16412
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:25051
    - key: negatively regulates
      source: MESH:D011112
      target: InterPro:IPR005025
    - key: part of
      source: CHEBI:16412
      target: GO:0009274
    - key: part of
      source: CHEBI:25051
      target: GO:0009274
    - key: part of
      source: InterPro:IPR005025
      target: GO:0045272
    - key: in taxon
      source: GO:0009274
      target: NCBITaxon:2
    - key: in taxon
      source: GO:0045272
      target: NCBITaxon:2
    - key: causes
      source: NCBITaxon:2
      target: MESH:D010032
  multigraph: true
  nodes:
    - id: MESH:D011112
      label: Drug
      name: Polymyxin B
    - id: CHEBI:16412
      label: ChemicalSubstance
      name: lipopolysaccharide
    - id: CHEBI:25051
      label: ChemicalSubstance
      name: Lipid A
    - id: InterPro:IPR005025
      label: GeneFamily
      name: NADPH-dependent FMN reductase-like
    - id: GO:0009274
      label: CellularComponent
      name: peptidoglycan-based cell wall
    - id: GO:0045272
      label: CellularComponent
      name: plasma membrane respiratory chain complex I
    - id: NCBITaxon:2
      label: OrganismTaxon
      name: Bacteria
    - id: MESH:D010032
      label: Disease
      name: Otitis externa
  reference:
    - https://go.drugbank.com/drugs/DB00781#mechanism-of-action
    - https://en.wikipedia.org/wiki/Polymyxin_B#Mechanism_of_action
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355641/
- directed: true
  graph:
    _id: DB00781_MESH_D007634_1
    disease: Keratitis
    disease_mesh: MESH:D007634
    drug: Polymyxin B
    drug_mesh: MESH:D011112
    drugbank: DB:DB00781
  links:
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:16412
    - key: disrupts
      source: MESH:D011112
      target: CHEBI:25051
    - key: negatively regulates
      source: MESH:D011112
      target: InterPro:IPR005025
    - key: part of
      source: CHEBI:16412
      target: GO:0009274
    - key: part of
      source: CHEBI:25051
      target: GO:0009274
    - key: part of
      source: InterPro:IPR005025
      target: GO:0045272
    - key: in taxon
      source: GO:0009274
      target: NCBITaxon:1280
    - key: in taxon
      source: GO:0045272
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D007634
  multigraph: true
  nodes:
    - id: MESH:D011112
      label: Drug
      name: Polymyxin B
    - id: CHEBI:16412
      label: ChemicalSubstance
      name: lipopolysaccharide
    - id: CHEBI:25051
      label: ChemicalSubstance
      name: Lipid A
    - id: InterPro:IPR005025
      label: GeneFamily
      name: NADPH-dependent FMN reductase-like
    - id: GO:0009274
      label: CellularComponent
      name: peptidoglycan-based cell wall
    - id: GO:0045272
      label: CellularComponent
      name: plasma membrane respiratory chain complex I
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D007634
      label: Disease
      name: Keratitis
  reference:
    - https://go.drugbank.com/drugs/DB00781#mechanism-of-action
    - https://en.wikipedia.org/wiki/Polymyxin_B#Mechanism_of_action
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355641/
- directed: true
  graph:
    _id: DB01261_MESH_D003924_1
    disease: Diabetes mellitus type 2
    disease_mesh: MESH:D003924
    drug: sitagliptin
    drug_mesh: MESH:D000068900
    drugbank: DB:DB01261
  links:
    - key: negatively regulates
      source: MESH:D000068900
      target: UniProt:P27487
    - key: participates in
      source: UniProt:P27487
      target: REACT:R-HSA-381771
    - key: participates in
      source: UniProt:P27487
      target: REACT:R-HSA-400511
    - key: negatively correlated with
      source: REACT:R-HSA-381771
      target: GO:0030073
    - key: negatively correlated with
      source: REACT:R-HSA-400511
      target: GO:0030073
    - key: positively correlated with
      source: REACT:R-HSA-381771
      target: GO:0070091
    - key: positively correlated with
      source: REACT:R-HSA-400511
      target: GO:0070091
    - key: positively correlated with
      source: GO:0070091
      target: MESH:D003924
    - key: negatively correlated with
      source: GO:0030073
      target: MESH:D003924
  multigraph: true
  nodes:
    - id: MESH:D000068900
      label: Drug
      name: sitagliptin
    - id: UniProt:P27487
      label: Protein
      name: Dipeptidyl peptidase 4
    - id: REACT:R-HSA-381771
      label: Pathway
      name: Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
    - id: REACT:R-HSA-400511
      label: Pathway
      name: Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
    - id: GO:0030073
      label: BiologicalProcess
      name: Insulin Secretion
    - id: GO:0070091
      label: BiologicalProcess
      name: glucagon secretion
    - id: MESH:D003924
      label: Disease
      name: Diabetes mellitus type 2
  reference:
    - https://go.drugbank.com/drugs/DB01261#mechanism-of-action
    - https://en.wikipedia.org/wiki/Sitagliptin
    - https://en.wikipedia.org/wiki/Dipeptidyl_peptidase-4_inhibitor
    - https://en.wikipedia.org/wiki/Incretin#Medical_uses
    - https://en.wikipedia.org/wiki/Type_2_diabetes#Pathophysiology
- directed: true
  graph:
    _id: DB00661_MESH_D006973_1
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: InterPro:IPR005446
    - key: positively regulates
      source: InterPro:IPR005446
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0033533
    - key: positively correlated with
      source: HP:0033533
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033533
      label: PhenotypicFeature
      name: Increased cardiac output
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference:
    - https://go.drugbank.com/drugs/DB00661#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/
    - https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
- directed: true
  graph:
    _id: DB00661_MESH_D001281_1
    disease: Atrial fibrillation
    disease_mesh: MESH:D001281
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: InterPro:IPR005446
    - key: positively regulates
      source: InterPro:IPR005446
      target: GO:0061337
    - key: positively correlated with
      source: GO:0061337
      target: GO:0060047
    - key: positively correlated with
      source: GO:0060047
      target: HP:0001692
    - key: manifestation of
      source: HP:0001692
      target: MESH:D001281
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: GO:0061337
      label: BiologicalProcess
      name: cardiac conduction
    - id: GO:0060047
      label: BiologicalProcess
      name: heart contraction
    - id: HP:0001692
      label: PhenotypicFeature
      name: Atrial arrhythmia
    - id: MESH:D001281
      label: Disease
      name: Atrial fibrillation
  reference:
    - https://go.drugbank.com/drugs/DB00661#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/
    - https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
    - https://en.wikipedia.org/wiki/Atrial_fibrillation#Rate_control
- directed: true
  graph:
    _id: DB00661_MESH_D054058_1
    disease: Acute coronary syndrome
    disease_mesh: MESH:D054058
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: InterPro:IPR005446
    - key: positively regulates
      source: InterPro:IPR005446
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0033401
    - key: positively correlated with
      source: HP:0033401
      target: MESH:D054058
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033401
      label: PhenotypicFeature
      name: Tissue ischemia
    - id: MESH:D054058
      label: Disease
      name: Acute coronary syndrome
  reference:
    - https://go.drugbank.com/drugs/DB00661#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/
    - https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
- directed: true
  graph:
    _id: DB00661_MESH_D000787_1
    disease: Angina pectoris
    disease_mesh: MESH:D000787
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: InterPro:IPR005446
    - key: positively regulates
      source: InterPro:IPR005446
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0033401
    - key: positively correlated with
      source: HP:0033401
      target: MESH:D000787
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033401
      label: PhenotypicFeature
      name: Tissue ischemia
    - id: MESH:D000787
      label: Disease
      name: Angina pectoris
  reference:
    - https://go.drugbank.com/drugs/DB00661#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/
    - https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
    - https://en.wikipedia.org/wiki/Angina#Treatment
- directed: true
  graph:
    _id: DB00661_MESH_D000788_1
    disease: Angina Pectoris, Variant
    disease_mesh: MESH:D000788
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: InterPro:IPR005446
    - key: positively regulates
      source: InterPro:IPR005446
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0033401
    - key: positively correlated with
      source: HP:0033401
      target: MESH:D000788
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: InterPro:IPR005446
      label: GeneFamily
      name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033401
      label: PhenotypicFeature
      name: Tissue ischemia
    - id: MESH:D000788
      label: Disease
      name: Angina Pectoris, Variant
  reference:
    - https://go.drugbank.com/drugs/DB00661#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/
    - https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
    - https://en.wikipedia.org/wiki/Variant_angina#Maintenance
  comment: The disease is also known as as Prinzmetal angina.
- directed: true
  graph:
    _id: DB01144_MESH_D005902_1
    disease: Open-angle glaucoma
    disease_mesh: MESH:D005902
    drug: dichlorphenamide
    drug_mesh: MESH:D004005
    drugbank: DB:DB01144
  links:
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P00915
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P00918
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P22748
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P43166
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:O43570
    - key: positively regulates
      source: UniProt:P00915
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P00918
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P22748
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P43166
      target: GO:0015701
    - key: positively regulates
      source: UniProt:O43570
      target: GO:0015701
    - key: increases abundance of
      source: GO:0015701
      target: UBERON:0001796
    - key: positively correlated with
      source: UBERON:0001796
      target: HP:0007906
    - key: positively correlated with
      source: HP:0007906
      target: MESH:D005902
  multigraph: true
  nodes:
    - id: MESH:D004005
      label: Drug
      name: dichlorphenamide
      alt_names:
        - Diclofenamide
    - id: UniProt:P00915
      label: Protein
      name: Carbonic anhydrase 1
    - id: UniProt:P00918
      label: Protein
      name: Carbonic anhydrase 2
    - id: UniProt:P22748
      label: Protein
      name: Carbonic anhydrase 4
    - id: UniProt:P43166
      label: Protein
      name: Carbonic anhydrase 7
    - id: UniProt:O43570
      label: Protein
      name: Carbonic anhydrase 12
    - id: GO:0015701
      label: BiologicalProcess
      name: bicarbonate transport
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: HP:0007906
      label: PhenotypicFeature
      name: Ocular Hypertension
    - id: MESH:D005902
      label: Disease
      name: Open-angle glaucoma
  reference:
    - https://go.drugbank.com/drugs/DB01144#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL17/
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC506660/
    - https://en.wikipedia.org/wiki/Glaucoma#Medication
    - https://www.aaopt.org/docs/knowledge-base/outline26514.doc?sfvrsn=5f863d3_0
    - https://en.wikipedia.org/wiki/Aqueous_humour#Clinical_significance
- directed: true
  graph:
    _id: DB01144_MESH_D015812_1
    disease: Angle-closure glaucoma
    disease_mesh: MESH:D015812
    drug: dichlorphenamide
    drug_mesh: MESH:D004005
    drugbank: DB:DB01144
  links:
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P00915
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P00918
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P22748
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:P43166
    - key: negatively regulates
      source: MESH:D004005
      target: UniProt:O43570
    - key: positively regulates
      source: UniProt:P00915
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P00918
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P22748
      target: GO:0015701
    - key: positively regulates
      source: UniProt:P43166
      target: GO:0015701
    - key: positively regulates
      source: UniProt:O43570
      target: GO:0015701
    - key: increases abundance of
      source: GO:0015701
      target: UBERON:0001796
    - key: positively correlated with
      source: UBERON:0001796
      target: HP:0007906
    - key: positively correlated with
      source: HP:0007906
      target: MESH:D015812
  multigraph: true
  nodes:
    - id: MESH:D004005
      label: Drug
      name: dichlorphenamide
      alt_names:
        - Diclofenamide
    - id: UniProt:P00915
      label: Protein
      name: Carbonic anhydrase 1
    - id: UniProt:P00918
      label: Protein
      name: Carbonic anhydrase 2
    - id: UniProt:P22748
      label: Protein
      name: Carbonic anhydrase 4
    - id: UniProt:P43166
      label: Protein
      name: Carbonic anhydrase 7
    - id: UniProt:O43570
      label: Protein
      name: Carbonic anhydrase 12
    - id: GO:0015701
      label: BiologicalProcess
      name: bicarbonate transport
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: HP:0007906
      label: PhenotypicFeature
      name: Ocular Hypertension
    - id: MESH:D015812
      label: Disease
      name: Angle-closure glaucoma
  reference:
    - https://go.drugbank.com/drugs/DB01144#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL17/
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC506660/
    - https://en.wikipedia.org/wiki/Glaucoma#Medication\
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC506660/
    - https://www.aaopt.org/docs/knowledge-base/outline26514.doc?sfvrsn=5f863d3_0
    - https://en.wikipedia.org/wiki/Aqueous_humour#Clinical_significance

